Frank Aboubakar-Nana

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

Journal: The Lancet. Oncology

Published: December 20, 2025

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Journal: JTO clinical and research reports

Published: September 09, 2025

Effect of fan therapy on dyspnea in patients with chronic respiratory diseases during exercise: A randomized controlled trial.

Effect of fan therapy on dyspnea in patients with chronic respiratory diseases during exercise: A randomized controlled trial.

Journal: Respiratory medicine

Published: August 04, 2025

Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders.

Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders.

Journal: JAMA network open

Published: June 04, 2025

GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors.

GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors.

Journal: Cancer immunology, immunotherapy : CII

Published: April 15, 2025

Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial.

Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial.

Journal: Translational lung cancer research

Published: February 27, 2025

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

Journal: Nature communications

Published: February 13, 2025

Deciphering neutrophil heterogeneity in human blood and tumors: Methods for isolating neutrophils and assessing their effect on T-cell proliferation.

Deciphering neutrophil heterogeneity in human blood and tumors: Methods for isolating neutrophils and assessing their effect on T-cell proliferation.

Journal: Methods in cell biology

Published: January 17, 2025

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.

Journal: Journal for immunotherapy of cancer

Published: December 29, 2024

Assessment of Muscular Strength and Functional Capacity in Smoker Population Without Any Diagnosed Respiratory Disease: A Cross-Sectional Study.

Assessment of Muscular Strength and Functional Capacity in Smoker Population Without Any Diagnosed Respiratory Disease: A Cross-Sectional Study.

Journal: Healthcare (Basel, Switzerland)

Published: December 16, 2024

A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

Journal: BMC cancer

Published: October 28, 2024

Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications.

Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications.

Journal: JTO clinical and research reports

Published: June 26, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026